IL4 and melanoma: Furthermore, in the B16F10 melanoma model, PGD2 was able to restrain IFNγ production, but not IL-4, by invariant NKT cells, reducing the protective effects of the iNKT ligand alpha-GalCer against experimental metastasis, in vivo (200).